Capel Cure Sharp (CCS) is looking for a new lead fund manager for its Ethical fund to replace Fleur ...
Capel Cure Sharp (CCS) is looking for a new lead fund manager for its Ethical fund to replace Fleur Leach, who is standing down at the end of August 2000, writes Robert Stock.
Leach, who has worked for a total of eight years in ethical investments for Albert E Sharp and then CCS, is taking a sabatical period of up to six months to go travelling.
Capel Cure Sharp has said Leach intends to return to take up a new role within the ethical team as head of research. Barry Russell, head of investment fund development said CCS is well advanced in the replacement recruitment process and expects to announce Leach's successor soon. He said: "We are losing a respected and established name, and the important thing is we replace her with another established name."
Russell said Leach has been very successful since the launch two years ago of the CCS Ethical Fund, which, according to Standard & Poor's, is ranked 12 out of 299 companies in the UK All Companies sector over the 12 months up to 21 June, 2000 with offer to bid returns of 33.1%.
As Investment Week reported on 12 June, the CCS Ethical Fund has struggled since mid-March along with the CCS UK Growth Fund, run by Logie Cassels, and the CCS UK Opportunities Fund, run by Kenneth Levy.
All three fund managers work closely and share a belief in the TMT story and have all suffered in the recent value bounce.
Staying invested could prove lucrative
Consider lasting powers of attorney
Less environment, more governance threatens to undermine firms' green credentials
Evidence your compliance